Drug utilisation pattern and risk factor assessment on abnormal uterine bleeding in reproductive aged women in a tertiary care hospital

Abstract

To study the drug utilization pattern and risk factor assessment on abnormal uterine bleeding in reproductive-aged women in a tertiary care hospital at Salem district, Tamil Nadu, India. This retrospective study was carried out for a period of 6 months from November 2017 to April 2018 in which 150 prescriptions were selected for study by considering the inclusion and exclusion criteria. A total of 150 prescriptions were analyzed in reproductive-aged women. Patients of age group between 41-50 years were mostly diagnosed 75 (50%) of abnormal uterine bleeding. Considering the types of AUB, most of the patients (39.33%) which has been diagnosed as adenomyosis while 59 (32.67%) of the patient has been diagnosed leiomyoma 49 (32.67%). Anaemia 102 (68%) are the most seen co-morbid condition in our survey, along with Hypertension 28 (18.6%), Infective disorders 28 (18.6%). Our findings showed that among the drugs prescribed, that antifibrinolytics were the most often prescribed drug class for AUB, and the most prescribed drug is tranexamic acid. Perimenopause 57 (38%) is the main risk factor in abnormal uterine bleeding, along with dysfunctional uterine bleeding 47 (32.6%). From we concluded that The mostly used class of drug for abnormal uterine bleeding in our tertiary care hospital is antifibrinolytics and mostly used drug agent is tranexamic acid during the period of data collection. It is found to be that perimenopause is the main risk factor in abnormal uterine bleeding along with dysfunctional uterine bleeding.

Evaluation Of Medicine Prescription At A Pharmacy In Medan City

“…Irrational drug use will cause many negative impacts, such as high burden of medical cost, the increasing risk of antimicrobial resistance, adverse drugs effects, harmful and improper drug interactions that may reduce the efficacy of the drugs and even may cause death. Therefore, drug use evaluation will become one of the indicator in assessing health program [9,11].…”

A review on steps involved in drug utilization review

“…Inappropriate use of the drug can also tend to hike in medical cost, development of antimicrobial resistance, ADR and mortality of Patients. Therefore the drug utilization (DUE) studies become one of the impending tools in the assessment of the health program (Ramalingam et al, 2019;Shalini, 2010). Drug Use Evaluation (DUE) or Drug Utilization Evaluation is the management of continuous, precise, criteria-based assessments of the use of drugs, which will warrant that the drugs are being used relevantly, which is at the extent of the patient (Holloway and Green, 2003).…”